Injection Pen Market Size And Share

  • Report Code : TIPRE00002867
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Injection Pen Market Size, Segments, and Trends by 2031

Buy Now

Injection Pen Market Report Injection Pen Market Scope and Analysis Injection Pen Market Size and Share

Injection Pen Market: Strategic Insights

Injection Pen Market

  • CAGR (2023 - 2031)
    7.14%
  • Market Size 2023
    US$ 42.70 Billion
  • Market Size 2031
    US$ 74.20 Billion

Market Dynamics

GROWTH DRIVERS
  • Higher Prevalence of Chronic Disorders Boosting Market Growth
FUTURE TRENDS
  • Strategic Developments by Various Players Favouring Market Growth
OPPORTUNITIES
  • Increasing Biologics Patent Expiry and Use of Biosimilars Generating the Demand for Injection Pens

Key Players

  • Eli Lilly and Co
  • Novo Nordisk AS
  • Owen Mumford Ltd
  • Sanofi SA
  • Merck KGaA
  • Haselmeier GmbH
  • Gerresheimer AG
  • Becton Dickinson and Co
  • AstraZeneca Plc
  • Teva Pharmaceutical Industries Ltd

Regional Overview

  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

Type
  • Disposable Injection Pens and Reusable Injection Pens
Therapy
  • Diabetes
  • Growth Hormone Therapy
  • Autoimmune Diseases
  • Fertility
  • Cancer
  • Other Therapies
End User
  • Hospitals and Clinics
  • Home Care